IMU 18 Sep 2025, 9:29 AM

Overall Response Rate increases to 81% in azer-cel trial

Imugene Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in